tsn

AI Platform eCARTv5 for Predicting Deterioration in Hospitalized Patients Superior to Epic’s Deterioration Index

 83
0 comment
Staff at TrialSite | Quality Journalism
Oct. 29, 2024, 4:00 p.m.

A recent study compared the performance of several early warning scores for detecting clinical deterioration in hospitalized patients, focusing on AI-based and non-AI-based tools, using data from seven hospitals. This retrospective cohort study centered on the Yale New Haven Health System. The authors documented all consecutive adult medical-surgical ward hospital encounters between March 9, 2019, and November 9, 2023, comparing six early warning scores across 362?926 patient encounters, with eCARTv5, a machine learning mode used to identify clinical deterioration best with an area under the receiver operating characteristics curve (AUROC) of 0.895 and the highest positive predictive values at both the moderate- and high-risk matched thresholds. The National Early Warning Score, a non–artificial intelligence score with an AUROC of 0.831, was the second-best performer at both thresholds, while the Epic Deterioration Index (EDI), a predictive tool integrated within the Epic electronic health record (EHR) system, was one of the worst, with an AUROC of 0.808 and the lowest positive predictive values. The latter Epic system uses patient data to assess and predict the risk of clinical deterioration, aiming to alert healthcare providers early to patients who may need intervention to prevent worsening conditions.

Brief review of eCARTv5

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News